Experienced in Lung Nodules

Dr. Carlos A. Rodriguez

Pediatric Hematology Oncology
262 Danny Thomas Pl, 
Memphis, TN 
Experienced in Lung Nodules
262 Danny Thomas Pl, 
Memphis, TN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Carlos Rodriguez is a Pediatric Hematologist Oncology provider in Memphis, Tennessee. Dr. Rodriguez is rated as an Experienced provider by MediFind in the treatment of Lung Nodules. His top areas of expertise are Germ Cell Tumor, Retinoblastoma, Langerhans Cell Histiocytosis, Hepatectomy, and Tissue Biopsy.

His clinical research consists of co-authoring 275 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Lung Nodules.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in TN
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO

Locations

262 Danny Thomas Pl, Memphis, TN 38105

Additional Areas of Focus

Dr. Rodriguez has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)
Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children With Cancer
Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children With Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 18, 2025
Intervention Type: Other, Procedure
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
Enrollment Status: Active_not_recruiting
Publish Date: August 11, 2025
Intervention Type: Drug, Other, Procedure
Study Drugs: Cisplatin, Dexrazoxane, Doxorubicin Hydrochloride, Fluorouracil, Irinotecan Hydrochloride, Temsirolimus, Vincristine Sulfate
Study Phase: Phase 3
Renal Tumors Classification, Biology, and Banking Study
Renal Tumors Classification, Biology, and Banking Study
Enrollment Status: Active_not_recruiting
Publish Date: March 25, 2025
Intervention Type: Other
A Phase 1 Study of Selinexor (KPT-330), A Selective XPO1 Inhibitor, in Recurrent and Refractory Pediatric Solid Tumors, Including CNS Tumors
A Phase 1 Study of Selinexor (KPT-330), A Selective XPO1 Inhibitor, in Recurrent and Refractory Pediatric Solid Tumors, Including CNS Tumors
Enrollment Status: Completed
Publish Date: January 14, 2025
Intervention Type: Drug, Other
Study Drug: Selinexor
Study Phase: Phase 1
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Enrollment Status: Completed
Publish Date: November 19, 2024
Intervention Type: Drug, Radiation
Study Phase: Phase 2
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
Enrollment Status: Active_not_recruiting
Publish Date: October 26, 2024
Intervention Type: Drug, Radiation, Biological, Other
Study Drugs: Carboplatin, Cisplatin, Cyclophosphamide, Etoposide, Vincristine
Study Phase: Phase 3
A Multi-institutional Feasibility Study of Intra-arterial Chemotherapy Given in the Ophthalmic Artery of Children With Retinoblastoma
A Multi-institutional Feasibility Study of Intra-arterial Chemotherapy Given in the Ophthalmic Artery of Children With Retinoblastoma
Enrollment Status: Completed
Publish Date: October 13, 2023
Intervention Type: Drug
Study Phase: Phase 1
A COG Study for Collecting and Banking Ewing Sarcoma Specimens
A COG Study for Collecting and Banking Ewing Sarcoma Specimens
Enrollment Status: Completed
Publish Date: October 03, 2023
Intervention Type: Other
A COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol
A COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol
Enrollment Status: Completed
Publish Date: October 03, 2023
Intervention Type: Other
Impact of Cleansing With Chlorhexidine Gluconate (CHG) on Reducing Central Line Associated Bloodstream Infection (CLABSI) and Acquisition of Multi-drug Resistant Organisms (MDRO) in Children With Cancer or Those Receiving Allogeneic Hematopoietic Cell Transplantation (HCT)
Impact of Cleansing With Chlorhexidine Gluconate (CHG) on Reducing Central Line Associated Bloodstream Infection (CLABSI) and Acquisition of Multi-drug Resistant Organisms (MDRO) in Children With Cancer or Those Receiving Allogeneic Hematopoietic Cell Transplantation (HCT)
Enrollment Status: Completed
Publish Date: June 22, 2021
Intervention Type: Procedure, Other
Study Phase: Phase 3
Treatment of Recurrent or Resistant Pediatric Malignant Germ Cell Tumors With Paclitaxel, Ifosfamide and Carboplatin
Treatment of Recurrent or Resistant Pediatric Malignant Germ Cell Tumors With Paclitaxel, Ifosfamide and Carboplatin
Enrollment Status: Completed
Publish Date: August 29, 2018
Intervention Type: Biological, Drug, Other
Study Phase: Phase 2
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens Including Rare Pediatric Tumors
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens Including Rare Pediatric Tumors
Enrollment Status: Completed
Publish Date: July 19, 2018
Intervention Type: Other
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Brain Tumor Research Specimens
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Brain Tumor Research Specimens
Enrollment Status: Completed
Publish Date: July 16, 2018
Intervention Type: Other
View 12 Less Clinical Trials

275 Total Publications

Translating the science of care and cure for children with cancer.
Translating the science of care and cure for children with cancer.
Journal: Cell reports. Medicine
Published: August 14, 2025
Similar Doctors
Experienced in Lung Nodules
Dr. Sheri L. Spunt
Pediatric Hematology Oncology
Experienced in Lung Nodules
Dr. Sheri L. Spunt
Pediatric Hematology Oncology
262 Danny Thomas Pl, 
Memphis, TN 
 (0.1 miles away)
901-595-3006
Languages Spoken:
English

Sheri Spunt is a Pediatric Hematologist Oncology provider in Memphis, Tennessee. Dr. Spunt is rated as a Distinguished provider by MediFind in the treatment of Lung Nodules. Her top areas of expertise are Adult Soft Tissue Sarcoma, Rhabdomyosarcoma, Osteosarcoma, Ewing Sarcoma, and Bone Marrow Aspiration.

Experienced in Lung Nodules
Dr. Ugochi O. Ogu
Hematology Oncology | Hematology | Pediatrics
Experienced in Lung Nodules
Dr. Ugochi O. Ogu
Hematology Oncology | Hematology | Pediatrics

UT Regional One Physicians Inc

880 Madison Ave, 
Memphis, TN 
 (1.2 miles away)
901-545-6969
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ugochi Ogu is a Hematologist Oncology specialist and a Hematologist in Memphis, Tennessee. Dr. Ogu is rated as a Distinguished provider by MediFind in the treatment of Lung Nodules. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia. Dr. Ogu is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rodriguez's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile